Suita, Japan

Ryu Nagata

This inventor holds 1 USPTO granted patent. Top assignees: Inter-University Research Institute Corporation National Institutes of Natural Sciences, Kyoto University, Osaka University. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryu Nagata. Retrieved from https://idiyas.com/inventor/ryu-nagata-gdpy4v8w

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ryu Nagata: Innovator in Benzisoxazole Compounds

Introduction

Ryu Nagata is a notable inventor based in Suita, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have therapeutic potential.

Latest Patents

Nagata holds a patent for a benzisoxazole compound, which is effective for preventing and/or treating fibrosis. The compound is represented by a specific chemical formula, where various components are defined, including an optionally substituted benzene ring and other structural elements that contribute to its efficacy.

Career Highlights

Throughout his career, Ryu Nagata has worked with prestigious institutions such as Osaka University and Kyoto University. His research has focused on innovative solutions in the realm of pharmaceuticals, particularly in addressing complex medical conditions.

Collaborations

Some of his notable coworkers include Yasuo Mori and Masayuki Mori. Their collaborative efforts have contributed to advancements in their respective fields.

Conclusion

Ryu Nagata's work in developing benzisoxazole compounds showcases his commitment to innovation in medicinal chemistry. His contributions are valuable in the ongoing quest for effective treatments for fibrosis and other medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…